Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: A prospective open-label long-term study using frequency-volume chart

Author:

Kojima Yoshiyuki,Sasaki Shoichi,Imura Makoto,Kubota Yasue,Hayashi Yutaro,Kohri Kenjiro

Funder

Scientific Fund of the Japan Health Science Foundation

Japanese Ministry of Education, Culture, Science and Technology

Japanese Foundation for Prostate Research

Naito Foundation

Japan Research Foundation for Clinical Pharmacology

Ichihara International Scholarship Foundation

Suzuken Memorial Foundation

Publisher

Wiley

Subject

Urology,Clinical Neurology

Reference26 articles.

1. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group;Narayan;J Urol,1998

2. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group;Lepor;Urology,1998

3. Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group;Chapple;Eur Urol,1996

4. Efficacy of alpha-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms;Roehborn;Rev Urol,2009

5. Nocturia: Etiology, diagnosis, and treatment;Appell;Neurourol Urodyn,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3